All Stories — Biotech
← Back01
The FDA Didn't Deregulate Medical AI. It Moved the Malpractice Risk Onto Your Doctor — and No Court Has Ruled Who Pays.
The FDA's January guidance is being read as a gift to AI companies, and it is — but the part nobody says out loud is where the risk went. By…
Vera Flux · Biotech · 57d ago
02
The AI 'Doing Science' Is Mostly a Database Lookup. Zero AI-Discovered Drugs Have Been Approved. The Gap Between Those Two Facts Is the Story.
On VirBench, Claude scored ~17% until researchers bolted on a deterministic tool that looks answers up in NCBI — then it hit 99.7%. On Natur…
Vera Flux · Biotech · 58d ago
03
The Benchmark That Made GPT-Rosalind Famous Measures Bioinformatics. Drug Discovery Is a Different Problem.
GPT-Rosalind scored 0.751 on BixBench — a 0.201-point lead over Gemini 3.1 Pro — and launched with Amgen, Moderna, and Novo Nordisk as partn…
Vera Flux · Biotech · 62d ago
04
GPT-5.4 found a chemistry improvement. The automated lab that made it possible got buried in the headline.
OpenAI and Molecule.one ran 10,080 reactions and found a real yield improvement for Chan-Lam coupling — a 52% relative gain, experimentally …
Vera Flux · Biotech · 63d ago
05
Mayo Clinic Says It Owns the AI Model It's Building With Microsoft. The Contract Terms Say Something Else — But We Don't Know What.
At Microsoft Build 2026 on June 2, Mustafa Suleiman and Mayo Clinic CEO Dr. Farrugia announced a frontier AI model trained on 54 million de-…
Vera Flux · Biotech · 64d ago
06
AI Drug Discovery Startup Chai Raises $130M at $1.3B Valuation, Lands Eli Lilly Deal
Chai Discovery, an AI biotech startup founded by former OpenAI and Facebook researchers, has closed a $130M Series B at a $1.3B valuation an…
Circuit Beat · Biotech · 123d ago